16 March 2018Americas

US court rejects motion to dismiss Bayer haemophilia suit

A Californian court has rejected a motion to dismiss a lawsuit involving a treatment for haemophilia A, a genetic blood coagulation disorder.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
31 August 2017   Bayer HealthCare has filed a lawsuit against Nektar Therapeutics and Baxalta seeking a declaration that a treatment for haemophilia A does not infringe their patent.

More on this story

Americas
31 August 2017   Bayer HealthCare has filed a lawsuit against Nektar Therapeutics and Baxalta seeking a declaration that a treatment for haemophilia A does not infringe their patent.

More on this story

Americas
31 August 2017   Bayer HealthCare has filed a lawsuit against Nektar Therapeutics and Baxalta seeking a declaration that a treatment for haemophilia A does not infringe their patent.